Human stakes behind biomedical progress.
Sounds of Science is a life sciences interview show centered on the human consequences of biomedical work. Mary Parker speaks with advocates, scientists, and nonprofit leaders about rare diseases, drug development, dialysis access, animal research ethics, and the practical gaps between discovery and care.
PRESS PLAY
Sounds of Science is a careful, interview-driven look at biomedical progress where laboratory work meets patients, families, and public health needs. Mary Parker guides the conversations with a calm, explanatory style. The show often begins close to home: a birth, a diagnosis, a parent’s fear, or a clinician’s problem in the field. Then it widens. Rare disease advocacy becomes a discussion of foundations, medical advisory boards, industry readiness, and the difficulty of building research plans around very small patient populations. Episodes on Mowat-Wilson syndrome, SPG50, and USP7-related diseases show how families move from shock to organizing, fundraising, and asking regulators for pathways that fit ultra-rare conditions. The science stays present. Conversations cover drug metabolism, genetic variation, prodrug activation, bioanalytical methods, endotoxins in dialysis water, PCR-based environmental health monitoring, and replacement, reduction, and refinement in animal research. It is not a show of quick takes. Guests are given space to explain what a tool does, why a rule matters, or how a partnership changes what is possible. The emotional stakes are high, but the copybook hero language is mostly avoided in favor of concrete work: finding families, funding research, testing water, improving welfare practices, or making a treatment portable. Charles River is part of the frame, and many episodes connect back to drug discovery, development, and applied research infrastructure. That gives the show a more industry-facing angle than a general science program. Still, the strongest moments are often personal. Parents talk about children with rare diseases. Advocates describe the need to be heard. Nonprofit leaders explain how clean water, training, or portraiture can change medical care and awareness. Sounds of Science is best for listeners who want life sciences with human scale, technical specificity, and a steady sense of why the work matters.
Made for: Best for listeners interested in life sciences, rare disease advocacy, drug development, medical access, and animal welfare. It fits people who prefer patient, expert-led conversations over simplified science headlines.
What sets it apart: The show pairs family and nonprofit stories with concrete biomedical and regulatory detail. Its strength is the bridge between personal urgency and the machinery of research, testing, welfare, and treatment development.
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
A Damascus dialysis clinic gives your curiosity about medical progress somewhere concrete to land.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A rare-disease family story becomes a grounded look at how advocacy helps make research possible.
The episode traces Lauren and Matt Noonan's path from their daughter Jane's Mowat-Wilson syndrome diagnosis into the steady, practical work of rare-disease advocacy.
A clear look at how drug metabolism, genetic variation, FDA work, and science communication can shape a research career.
Pharmacology comes through as a career shaped by small biological questions, then carried into places where medicine-focused science is studied, tested, and put to use. Dr.
Portable testing links contaminated water to fever and chills in a Damascus dialysis unit.
Dialysis in remote regions can hinge on something basic but unforgiving: water clean enough for treatment. Mary Parker’s conversation with Chris Atwater of Bridge of Life turns that challenge into fieldwork, moving from the limits of local laboratories to the value of portable…
A rare-disease episode that ties family urgency to the difficult mechanics of advancing a treatment.
SPG50 is rare enough that treating 28 children would reach roughly a quarter to a third of known cases worldwide, but this episode is less about scale than about the grind of turning one family's crisis into a possible therapy.
A therapeutic target gives USP7 rare-disease advocacy fresh momentum, while treatment remains uncertain.
A rare-disease foundation moves from the fear that help may arrive too late toward the possibility that it could still come in time. Sounds of Science follows Bo Bigelow, Amber Freed, and David Fisher as USP7-related research reaches the milestone of identifying a therapeutic…
Mushroom culture from soil to society.
Clear neuroscience for curious minds.
Plant papers, jokes, and useful uncertainty.
Weed science, from genomes to paddocks.
Biomedical careers, described from the inside.
Life science, one sharp discovery at a time.
A family shares their journey with Mowat-Wilson Syndrome, from diagnosis to founding a foundation for research and support.
Dr.
Chris Atwater discusses his journey from the Marines to biomedical technician and his work with Bridge of Life providing dialysis in remote regions.
Terry Paravalakis, CEO of Elpida Therapeutics, discusses the journey of developing a gene therapy for SPG50, a rare neurodegenerative disease affecting his son Michael.
Bo Bigelow and Amber Freed discuss the progress and hope in fighting USP7-related diseases through community-driven research and advocacy.
Patricia Welton discusses her art exhibit Beyond the Diagnosis, which uses portraits to humanize rare diseases for medical students and the public.
This episode explores the origins and mission of the North American 3Rs Collaborative, which aims to advance the refinement, reduction, and replacement of animal use in research.
This episode discusses the global impact of venomous snakebites and the mission of Ophirex to develop a modern, portable anti-venom.
Experts discuss the history and evolution of endotoxin testing, marking the 20th anniversary of EndoSafe cartridge technology.
A discussion about the 2012 fungal meningitis outbreak linked to the New England Compounding Center, exploring the definitions of compounding pharmacies and the regulatory changes that followed.